ACTBL2 and neoplasm: A tumor infiltration by ACTBL2-positive leukocytes was found to be significantly associated with improved overall survival of EOC patients (Fig. 1a; 61.2 (n = 99) vs. 34.4 (n = 29) months; p = 0.006).